Beyond clinical trials: Evolutionary and epidemiological considerations for development of a universal influenza vaccine
Cécile Viboud(Fogarty International Center), David Spiro(National Institutes of Health), Martha I. Nelson(National Center for Biotechnology Information), Amanda C. Perofsky(Northeastern University), Katelyn M. Gostic(University of California, Los Angeles), Benjamin J. Cowling(Peter Doherty Institute), Kaiyuan Sun(National Institutes of Health), Graeme E. Price(Center for Biologics Evaluation and Research), Nídia S. Trovão(National Institutes of Health), Suzanne L. Epstein(Center for Biologics Evaluation and Research)
Cited by 35
Related Papers
Estimates of global seasonal influenza-associated respiratory mortality: a modelling study
|The Lancet|2017|3k
Hand, foot, and mouth disease in China, 2008–12: an epidemiological study
|The Lancet Infectious Diseases|2014|965
Global mortality associated with seasonal influenza epidemics: New burden estimates and predictors from the GLaMOR Project
|Journal of Global Health|2019|717
The emergence of SARS-CoV-2 in Europe and North America
|Science|2020|426
The global H5N1 influenza panzootic in mammals
|Nature|2024|379